SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Henry J Henk, Xiaoyan Li, Laura K Becker, Hairong Xu, Qi Gong, Robert G Deeter, Richard L Barron, Comparative effectiveness of colony-stimulating factors in febrile neutropenia prophylaxis: how results are affected by research design, Journal of Comparative Effectiveness Research, 2015, 4, 1, 37

    CrossRef

  2. 2
    Bing Cai, Sean Hennessy, Vincent Lo Re, Dylan S. Small, Epidemiologic research using probabilistic outcome definitions, Pharmacoepidemiology and Drug Safety, 2015, 24, 1
  3. 3
    Donna A Messner, Penny Mohr, Adrian Towse, Futurescapes: evidence expectations in the USA for comparative effectiveness research for drugs in 2020, Journal of Comparative Effectiveness Research, 2015, 1

    CrossRef

  4. 4
    Sean Hennessy, Brian L. Strom, Improving Postapproval Drug Safety Surveillance: Getting Better Information Sooner, Annual Review of Pharmacology and Toxicology, 2015, 55, 1, 75

    CrossRef

  5. 5
    Jeffrey R. Curtis, Susana Perez-Gutthann, Samy Suissa, Pavel Napalkov, Natasha Singh, Liz Thompson, Benjamin Porter-Brown, Tocilizumab in rheumatoid arthritis: A case study of safety evaluations of a large postmarketing data set from multiple data sources, Seminars in Arthritis and Rheumatism, 2015, 44, 4, 381

    CrossRef

  6. 6
    S. V. Wang, S. Schneeweiss, M. Maclure, J. J. Gagne, "First-Wave" Bias When Conducting Active Safety Monitoring of Newly Marketed Medications with Outcome-Indexed Self-Controlled Designs, American Journal of Epidemiology, 2014, 180, 6, 636

    CrossRef

  7. 7
    Lorena Rocha Ayres, André de Oliveira Baldoni, Anna Paula de Sá Borges, Leonardo Régis Leira Pereira, Adherence and discontinuation of oral hormonal therapy in patients with hormone receptor positive breast cancer, International Journal of Clinical Pharmacy, 2014, 36, 1, 45

    CrossRef

  8. 8
    Robert LoCasale, David M. Kern, Pierre Chevalier, Siting Zhou, Soheil Chavoshi, Mark Sostek, Description of Cardiovascular Event Rates in Patients Initiating Chronic Opioid Therapy for Noncancer Pain in Observational Cohort Studies in the US, UK, and Germany, Advances in Therapy, 2014, 31, 7, 708

    CrossRef

  9. 9
    Gillian C. Hall, Fiona Hill, Descriptive investigation of the recording of influenza vaccination details on The Health Information Network database, Pharmacoepidemiology and Drug Safety, 2014, 23, 6
  10. 10
    Michael Goodman, Judy S. LaKind, Donald R. Mattison, Do phthalates act as obesogens in humans? A systematic review of the epidemiological literature, Critical Reviews in Toxicology, 2014, 44, 2, 151

    CrossRef

  11. You have free access to this content11
    Yi-Ying Chiang, Kuen-Bao Chen, Tung-Han Tsai, Wen-Chen Tsai, Lowered Cancer Risk With ACE Inhibitors/ARBs: A Population-Based Cohort Study, The Journal of Clinical Hypertension, 2014, 16, 1
  12. 12
    Elizabeth B. Andrews, Andrea V. Margulis, Patricia Tennis, Suzanne L. West, Opportunities and Challenges in Using Epidemiologic Methods to Monitor Drug Safety in the Era of Large Automated Health Databases, Current Epidemiology Reports, 2014, 1, 4, 194

    CrossRef

  13. 13
    Sun-Young Jung, Nam-Kyong Choi, Joongyub Lee, Byung-Joo Park, Use of big data for drug safety monitoring and decision making, Journal of the Korean Medical Association, 2014, 57, 5, 391

    CrossRef

  14. 14
    Xiaofeng Zhou, Sundaresan Murugesan, Harshvinder Bhullar, Qing Liu, Bing Cai, Chuck Wentworth, Andrew Bate, An Evaluation of the THIN Database in the OMOP Common Data Model for Active Drug Safety Surveillance, Drug Safety, 2013, 36, 2, 119

    CrossRef

  15. 15
    François Alla, Myriam Rosilio, Christian Funck-Brentano, Philippe Barthélémy, Sophie Brisset, Dominic Cellier, Olivier Chassany, Jean-Paul Demarez, Vincent Diebolt, Alain Francillon, Laetitia Gambotti, Hakima Hannachi, Philippe Lechat, François Lemaire, Michel Lièvre, Christophe Misse, Marina Nguon, Antoine Pariente, Michel Rosenheim, Nadine Weisslinger-Darmon, Comment garantir des données médicales de qualité dans les études cliniques, pharmaco-épidémiologiques et en pharmacovigilance ?, Thérapie, 2013, 68, 4, 209

    CrossRef

  16. 16
    François Alla, Myriam Rosilio, Christian Funck-Brentano, Philippe Barthélémy, Sophie Brisset, Dominic Cellier, Olivier Chassany, Jean-Paul Demarez, Vincent Diebolt, Alain Francillon, Laetitia Gambotti, Hakima Hannachi, Philippe Lechat, François Lemaire, Michel Lièvre, Christophe Misse, Marina Nguon, Antoine Pariente, Michel Rosenheim, Nadine Weisslinger-Darmon, How can the Quality of Medical Data in Pharmacovigilance, Pharmacoepidemiology and Clinical Studies be Guaranteed?, Thérapie, 2013, 68, 4, 217

    CrossRef

  17. 17
    Raymond L. Woosley, One Hundred Years of Drug Regulation: Where Do We Go from Here?, Annual Review of Pharmacology and Toxicology, 2013, 53, 1, 255

    CrossRef

  18. 18
    T A Hammad, G A Neyarapally, S Iyasu, J A Staffa, G Dal Pan, The Future of Population-Based Postmarket Drug Risk Assessment: A Regulator's Perspective, Clinical Pharmacology & Therapeutics, 2013, 94, 3
  19. 19
    Esi Morgan DeWitt, Hermine I. Brunner, The landscape of comparative effectiveness research in rheumatology, Nature Reviews Rheumatology, 2013, 10, 1, 57

    CrossRef

  20. 20
    Francisco J. de Abajo, Miguel J. Gil, Verónica Bryant, Julia Timoner, Belén Oliva, Luis A. García-Rodríguez, Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case–control study in a new general practice database, European Journal of Clinical Pharmacology, 2013, 69, 3, 691

    CrossRef

  21. 21
    Vincent Lo Re, Kevin Haynes, Eileen E. Ming, Jennifer Wood Ives, Laura N. Horne, Kimberly Fortier, Dena M. Carbonari, Sean Hennessy, Serena Cardillo, Peter P. Reese, K. Rajender Reddy, David Margolis, Andrea Apter, Stephen E. Kimmel, Jason Roy, Cristin P. Freeman, Hanieh Razzaghi, Crystal N. Holick, Daina B. Esposito, Tjeerd-Pieter Van Staa, Harshvinder Bhullar, Brian L. Strom, Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies, Pharmacoepidemiology and Drug Safety, 2012, 21, 11
  22. 22
    Soo Youn Chung, Sun-Young Jung, Ju-Young Shin, Byung-Joo Park, The role of the KIDS for enhancing drug safety and risk management in Korea, Journal of the Korean Medical Association, 2012, 55, 9, 861

    CrossRef

  23. 23
    Sengwee Toh, Susan E. Andrade, Marsha A. Raebel, Denise M. Boudreau, Robert L. Davis, Katherine Haffenreffer, Pamala A. Pawloski, Richard Platt, Sean Hennessy, Cristin Palumbo Freeman, Francesca Cunningham, Yola Moride, Alexis Ogdie, Sinéad M. Langan, John Parkinson, Hassy Dattani, Karel Kostev, Joel M. Gelfand, Ron M.C. Herings, Lars Pedersen, Examples of Existing Automated Databases,